SCHEMBL10169211

SCHEMBL10169211

Cc1nc2ccccc2c2sccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.57
ALDH1A1 P00352 2/20 0.52
CYP1A2 P05177 2/20 0.52
HSD17B10 Q99714 2/20 0.52
HPGD P15428 1/20 0.52
NUDT1 P36639 1/20 0.52
TLR8 Q9NR97 1/20 0.42
TLR7 Q9NYK1 1/20 0.42
HTT P42858 1/20 0.42
PDE10A Q9Y233 1/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CSNK2A1 P68400 3/20 0.40
MPO P05164 1/20 0.40
RAD52 P43351 1/20 0.40
TP53 P04637 1/20 0.40
ERN1 O75460 1/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3278516 0.79 GPR3 (0.53) GPR3ALDH1A1CYP1A2HSD17B10HPGD
SCHEMBL1451457 0.78 MAOA (0.45) ALDH1A1HTTMAPTKDM4ECSNK2A1
SCHEMBL27777002 0.78 TLR8 (0.50) ALDH1A1CYP1A2HSD17B10HPGDTLR8
SCHEMBL28435353 0.76 NUDT1 (0.49) ALDH1A1CYP1A2HPGDNUDT1HTT
SCHEMBL24853569 0.76 KDM4E (0.40) ALDH1A1CYP1A2HPGDTLR8TLR7
SCHEMBL27389038 0.74 ALDH1A1 (0.53) ALDH1A1PDE10AMAPTCSNK2A1
SCHEMBL6954052 0.74 NPSR1 (0.49) ALDH1A1HSD17B10HPGDHTTMAPT
SCHEMBL22431673 0.74 CSNK2A1 (0.38) GPR3ALDH1A1HPGDTLR8TLR7
SCHEMBL85621 0.73 GPR3 (1.00) GPR3ALDH1A1CYP1A2HSD17B10HPGD
SCHEMBL11932491 0.73 CSNK2A1 (0.45) GAACSNK2A1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170365800-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-12-21 US disclosed
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed
EP-1311487-B1 DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS MOLECULAR PROBES INC (US) 2008-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365800-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OSBP GPR3 2228/4885ALDH1A1 2016/4885CYP1A2 2156/4885
US-20090239859-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 GPR3 4263/4885ALDH1A1 3801/4885CYP1A2 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.